|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade receivables, net of allowance for expected credit losses of $21,856 and $23,528, respectively | ||||||||||||||||||||
| Financed receivables, short-term, net of allowance for expected credit losses of $3,781 and $3,112, respectively | ||||||||||||||||||||
| Materials and supplies | ||||||||||||||||||||
| Real estate assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Equipment and property, net of accumulated depreciation of $243,714 and $237,815, respectively | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Customer contracts, net | ||||||||||||||||||||
| Trademarks & tradenames, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Total intangible assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Financed receivables, long-term, net of allowance for expected credit losses of $10,045 and $7,922, respectively | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued insurance - current | ||||||||||||||||||||
| Accrued compensation and related liabilities | ||||||||||||||||||||
| Unearned revenues | ||||||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Accrued insurance, less current portion | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Other long-term accrued liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, without par value; 500,000 shares authorized, zero shares issued | ||||||||||||||||||||
| Common stock, par value $1 per share; 800,000,000 shares authorized, 478,012,174 and 481,193,751 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
